Tuberculosis (BCG) vaccine 2027-2029 (2029-2030, 2030-2031)

ired for vaccinating children under 7 years of age who belong to risk groups as part of the National Immunisation Program in Finland. The contract period is two (2) years during 2027-2029. The procurement contains two (2) one (1)-year contract period renewals (1 + 1) to extend the contract for the p

eriods 2029-2030 and 2030-2031. Estimated quantity for the contract period including contract period renewals is 92,000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will